Drugplain

DYANAVEL XR 5 mg/1

amphetamine · TABLET, EXTENDED RELEASE · NextWave Pharmaceuticals, Inc

No Recall HistoryCurrently in Shortage
Plain English

Dyanavel XR is an extended-release oral tablet containing amphetamine used to treat attention-deficit/hyperactivity disorder (ADHD) and narcolepsy. This central nervous system stimulant is available by prescription only.

Key Facts

Brand Name
DYANAVEL XR
Generic Name
amphetamine
NDC Code (Product)
24478-106
Manufacturer
NextWave Pharmaceuticals, Inc
Strength
5 mg/1
Dosage Form
TABLET, EXTENDED RELEASE
Route
ORAL
Marketing Status
DEA Schedule
Schedule II (Controlled)
Application #
NDA210526
Drug Class
Central Nervous System Stimulant [EPC]
Marketing Start
11/04/2021

Recall History

No Recall History

Frequently Asked Questions

What is DYANAVEL XR used for?

Dyanavel XR is an extended-release oral tablet containing amphetamine used to treat attention-deficit/hyperactivity disorder (ADHD) and narcolepsy. This central nervous system stimulant is available by prescription only.

Is DYANAVEL XR a controlled substance?

Yes, DYANAVEL XR is classified as CII under the DEA Controlled Substances Act.

What is the generic name for DYANAVEL XR?

The generic name for DYANAVEL XR is amphetamine. There are 12 other brand versions of amphetamine.

What is the NDC code for DYANAVEL XR 5 mg/1?

The NDC (National Drug Code) for DYANAVEL XR 5 mg/1 is 24478-106, listed by NextWave Pharmaceuticals, Inc.